Logo image of ATMV

ALPHAVEST ACQUISITION CORP (ATMV) Stock Fundamental Analysis

USA - NASDAQ:ATMV - KYG0283A1085 - Common Stock

22.2 USD
+7.09 (+46.92%)
Last: 9/19/2025, 8:00:00 PM
18.5 USD
-3.7 (-16.67%)
After Hours: 9/19/2025, 8:00:00 PM
Fundamental Rating

1

ATMV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ATMV may be in some trouble as it scores bad on both profitability and health. ATMV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ATMV was profitable.
In the past year ATMV had a positive cash flow from operations.
ATMV Yearly Net Income VS EBIT VS OCF VS FCFATMV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M 2M

1.2 Ratios

Industry RankSector Rank
ROA 5.37%
ROE 6.19%
ROIC N/A
ROA(3y)5.04%
ROA(5y)N/A
ROE(3y)5.39%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATMV Yearly ROA, ROE, ROICATMV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 5 10

1.3 Margins

ATMV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATMV Yearly Profit, Operating, Gross MarginsATMV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, ATMV has less shares outstanding
ATMV has a worse debt/assets ratio than last year.
ATMV Yearly Shares OutstandingATMV Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M
ATMV Yearly Total Debt VS Total AssetsATMV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

ATMV has an Altman-Z score of 13.64. This indicates that ATMV is financially healthy and has little risk of bankruptcy at the moment.
ATMV has a debt to FCF ratio of 39.17. This is a negative value and a sign of low solvency as ATMV would need 39.17 years to pay back of all of its debts.
ATMV has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 39.17
Altman-Z 13.64
ROIC/WACCN/A
WACCN/A
ATMV Yearly LT Debt VS Equity VS FCFATMV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ATMV has a Current Ratio of 0.02. This is a bad value and indicates that ATMV is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.02 indicates that ATMV may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
ATMV Yearly Current Assets VS Current LiabilitesATMV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

ATMV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.78%.
EPS 1Y (TTM)-58.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 148.00, the valuation of ATMV can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 27.38, ATMV is valued quite expensively.
Industry RankSector Rank
PE 148
Fwd PE N/A
ATMV Price Earnings VS Forward Price EarningsATMV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 1878.46
EV/EBITDA N/A
ATMV Per share dataATMV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ATMV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALPHAVEST ACQUISITION CORP

NASDAQ:ATMV (9/19/2025, 8:00:00 PM)

After market: 18.5 -3.7 (-16.67%)

22.2

+7.09 (+46.92%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-19 2025-08-19
Earnings (Next)11-19 2025-11-19
Inst Owners38.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap85.47M
AnalystsN/A
Price TargetN/A
Short Float %0.15%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 148
Fwd PE N/A
P/S N/A
P/FCF 1878.46
P/OCF 1878.46
P/B 5.23
P/tB 5.23
EV/EBITDA N/A
EPS(TTM)0.15
EY0.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY0.05%
OCF(TTM)0.01
OCFY0.05%
SpS0
BVpS4.24
TBVpS4.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.37%
ROE 6.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)5.04%
ROA(5y)N/A
ROE(3y)5.39%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 39.17
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 4.5%
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 13.64
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y110.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.34%
OCF growth 3YN/A
OCF growth 5YN/A